Anebulo Pharmaceuticals

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
EBITDA
-1,431
-2,403
-2,141
EBIT
-3,323
-2,403
-2,412
Net Income
-2,144
-1,676
-2,463
-2,201
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,652
-1,601
-1,405
-1,689
Cash
11,627
13,279
14,998
1,404
Basic Shares
41,084
27,415
27,415
25,933

Annual Financials

Values in thousands 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue
$0
$0
$0
$0
EBITDA
-9,223
-8,050
-11,783
5
EBIT
-8,308
-11,783
-6,825
Net Income
-8,484
-8,202
-11,732
-6,826
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,349
-8,090
-9,683
-5,437
Cash
11,627
3,094
11,247
14,548
Basic Shares
33,820
25,822
25,074
23,345

Earnings Calls

Quarter EPS
2025-09-30
-$0.05
2025-06-30
-$0.05
2025-03-31
-$0.04
2024-12-31
-$0.08